BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 17286297)

  • 1. Evaluation of the General Practice Research Database congenital heart defects prevalence: comparison to United Kingdom national systems.
    Wurst KE; Ephross SA; Loehr J; Clark DW; Guess HA
    Birth Defects Res A Clin Mol Teratol; 2007 Apr; 79(4):309-16. PubMed ID: 17286297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential of general practice data for congenital anomaly research: Comparison with registry data in the United Kingdom.
    Sokal R; Fleming KM; Tata LJ
    Birth Defects Res A Clin Mol Teratol; 2013 Aug; 97(8):546-53. PubMed ID: 23913362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Congenital heart defects in La Réunion Island: a 6-year survey within a EUROCAT-affiliated congenital anomalies registry.
    Bourdial H; Jamal-Bey K; Edmar A; Caillet D; Wuillai F; Bernede-Bauduin C; Boumahni B; Robillard PY; Kauffmann E; Laffitte A; Touret Y; Cuillier F; Fourmaintraux A; Alessandri JL; Gérardin P; Randrianaivo H
    Cardiol Young; 2012 Oct; 22(5):547-57. PubMed ID: 22325463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying major congenital malformations in the UK General Practice Research Database (GPRD): a study reporting on the sensitivity and added value of photocopied medical records and free text in the GPRD.
    Charlton RA; Weil JG; Cunnington MC; de Vries CS
    Drug Saf; 2010 Sep; 33(9):741-50. PubMed ID: 20701407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Determination of one national standard for children with congenital anomalies in the National Obstetrical Registry and in the National Neonatal Registry].
    Dorrepaal CA; den Ouden AL; Cornel MC
    Ned Tijdschr Geneeskd; 1998 Mar; 142(12):645-9. PubMed ID: 9623130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing a large electronic primary care database (Doctors' Independent Network) for research.
    Carey IM; Cook DG; De Wilde S; Bremner SA; Richards N; Caine S; Strachan DP; Hilton SR
    Int J Med Inform; 2004 Jun; 73(5):443-53. PubMed ID: 15171985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Data resources for investigating drug exposure during pregnancy and associated outcomes: the General Practice Research Database (GPRD) as an alternative to pregnancy registries.
    Charlton RA; Cunnington MC; de Vries CS; Weil JG
    Drug Saf; 2008; 31(1):39-51. PubMed ID: 18095745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validity of diagnostic coding within the General Practice Research Database: a systematic review.
    Khan NF; Harrison SE; Rose PW
    Br J Gen Pract; 2010 Mar; 60(572):e128-36. PubMed ID: 20202356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Association of H1N1 Pandemic Influenza with Congenital Anomaly Prevalence in Europe: An Ecological Time Series Study.
    Luteijn JM; Addor MC; Arriola L; Bianchi F; Garne E; Khoshnood B; Nelen V; Neville A; Queisser-Luft A; Rankin J; Rounding C; Verellen-Dumoulin C; de Walle H; Wellesley D; Wreyford B; Yevtushok L; de Jong-van den Berg L; Morris J; Dolk H
    Epidemiology; 2015 Nov; 26(6):853-61. PubMed ID: 26327589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The utility of the general practice research database to examine selected congenital heart defects: a validation study.
    Wurst KE; Ephross SA; Loehr J; Clark DW; Guess HA
    Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):867-77. PubMed ID: 17563909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer recording and mortality in the General Practice Research Database and linked cancer registries.
    Boggon R; van Staa TP; Chapman M; Gallagher AM; Hammad TA; Richards MA
    Pharmacoepidemiol Drug Saf; 2013 Feb; 22(2):168-75. PubMed ID: 23239282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paper 1: The EUROCAT network--organization and processes.
    Boyd PA; Haeusler M; Barisic I; Loane M; Garne E; Dolk H
    Birth Defects Res A Clin Mol Teratol; 2011 Mar; 91 Suppl 1():S2-15. PubMed ID: 21384531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of congenital anomalies in Europe.
    Dolk H; Loane M; Garne E
    Adv Exp Med Biol; 2010; 686():349-64. PubMed ID: 20824455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of the problem orientated medical record (POMR) for research using electronic GP databases: a comparison of the Doctors Independent Network Database (DIN) and the General Practice Research Database (GPRD).
    Carey IM; Cook DG; De Wilde S; Bremner SA; Richards N; Caine S; Strachan DP; Hilton SR
    BMC Fam Pract; 2003 Sep; 4():14. PubMed ID: 14516473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectrum of congenital anomalies in pregnancies with pregestational diabetes.
    Garne E; Loane M; Dolk H; Barisic I; Addor MC; Arriola L; Bakker M; Calzolari E; Matias Dias C; Doray B; Gatt M; Melve KK; Nelen V; O'Mahony M; Pierini A; Randrianaivo-Ranjatoelina H; Rankin J; Rissmann A; Tucker D; Verellun-Dumoulin C; Wiesel A
    Birth Defects Res A Clin Mol Teratol; 2012 Mar; 94(3):134-40. PubMed ID: 22371321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased prevalence of congenital heart defects in monozygotic and dizygotic twins.
    Herskind AM; Almind Pedersen D; Christensen K
    Circulation; 2013 Sep; 128(11):1182-8. PubMed ID: 23929909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The incidence of breast cancer in the General Practice Research Database compared with national cancer registration data.
    Kaye JA; Derby LE; del Mar Melero-Montes M; Quinn M; Jick H
    Br J Cancer; 2000 Dec; 83(11):1556-8. PubMed ID: 11076668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic lupus erythematosus prevalence in the UK: methodological issues when using the General Practice Research Database to estimate frequency of chronic relapsing-remitting disease.
    Nightingale AL; Farmer RD; de Vries CS
    Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):144-51. PubMed ID: 16700093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of vascular disruption anomalies and association with young maternal age: A EUROCAT study to compare the United Kingdom with other European countries.
    Morris JK; Wellesley D; Limb E; Bergman JEH; Kinsner-Ovaskainen A; Addor MC; Broughan JM; Cavero-Carbonell C; Dias CM; Echevarría-González-de-Garibay LJ; Gatt M; Haeusler M; Barisic I; Klungsoyr K; Lelong N; Materna-Kiryluk A; Neville A; Nelen V; O'Mahony MT; Perthus I; Pierini A; Rankin J; Rissmann A; Rouget F; Sayers G; Stevens S; Tucker D; Garne E
    Birth Defects Res; 2022 Dec; 114(20):1417-1426. PubMed ID: 36369770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comorbidity, healthcare utilisation and process of care measures in patients with congenital heart disease in the UK: cross-sectional, population-based study with case-control analysis.
    Billett J; Cowie MR; Gatzoulis MA; Vonder Muhll IF; Majeed A
    Heart; 2008 Sep; 94(9):1194-9. PubMed ID: 17646191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.